Skip to content

Periodontal Infection and Systemic Inflammation in Renal Patients

Periodontal Infection and Systemic Inflammation in Renal Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01094639
Acronym
PeriRen
Enrollment
52
Registered
2010-03-29
Start date
2009-08-31
Completion date
2015-08-31
Last updated
2016-10-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Periodontitis, Chronic Kidney Disease

Brief summary

The purpose of this study is to examine the role of gum disease in affecting the long term prognosis of renal patients. This disease if untreated causes inflammatory response throughout the body. If the subject has gum disease, he/she will be randomly assigned to one of the two treatment groups. The study investigates what happens to inflammatory markers in blood and saliva after you are treated for gum disease.

Detailed description

The main goal of this project was to explore the contribution of chronic periodontitis to systemic inflammation in Chronic Kidney Disease (CKD). To achieve this goal, the project had two specific objectives: 1. a) To compare the prevalence of periodontal infection between CKD and non-CKD populations and b) to explore the association between the presence of periodontal infection and the uremic status of CKD patients. 2. a) To assess the levels of systemic inflammatory markers, IL-6 and CRP in the presence or absence of periodontal infection in CKD and b) to compare the serum IL-6 and CRP levels in response to periodontal intervention.

Interventions

Deep gum cleaning with local anesthesia

Plaque removal

Sponsors

National Institute of Dental and Craniofacial Research (NIDCR)
CollaboratorNIH
UConn Health
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
21 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* dental subjects with periodontitis, * at least 10 teeth * no periodontal (gum) treatment for the last year, * no antibiotic for the last 4 months, * no vascular access infection.

Exclusion criteria

* smokers

Design outcomes

Primary

MeasureTime frameDescription
Serum Interleukin-6 (IL-6) and C-reactive protein (CRP) levels2 monthsIL-6 and CRP are markers of systemic inflammation and may improve at the end of gum treatment.

Secondary

MeasureTime frameDescription
Changes in periodontal (gum) clinical presentation and status2 monthsFor the secondary outcome, periodontal variables such as bleeding on probing, probing depth (the depth of the gum sulcus around the tooth), and bacterial plaque score will be evaluated to assess the effectiveness of the intervention and the compliance of the patients

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026